---

---

innovation   tags : China   

save search

---

Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published: 2024-04-02 (Crawled : 05:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -3.34% | O: -2.79% H: 1.32% C: 1.18%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.67% | O: -1.14% H: 0.02% C: -1.06%
review cancer treatment advanced china

---

HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published: 2024-04-02 (Crawled : 05:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -3.34% | O: -2.79% H: 1.32% C: 1.18%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.67% | O: -1.14% H: 0.02% C: -1.06%
HCM | $16.49 0.8% 0.79% 61K |

Health Technology

| -1.47% | O: 0.21% H: 1.49% C: -0.06%
treatment advanced china

---

Innovent and AnHeart Therapeutics Announce the NMPA of China Has Accepted Second NDA for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer
Published: 2024-03-05 (Crawled : 06:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -3.17% | O: 1.17% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -11.55% | O: 0.4% H: 0.38% C: -1.77%
lung cancer treatment therapeutics china

---

WISCO, China Unicom and ZTE recognized as "Best Mobile Innovation for Connected Economy" at the GLOMO Awards 2024
Published: 2024-02-29 (Crawled : 08:00) - prnewswire.com
ZTCOF | $1.91 -9.23% 200 |

Electronic Technology

| Email alert Add to watchlist
innovation awards mobile china

---

Innovent's First New Drug Application of Mazdutide for Chronic Weight Management has been Accepted by the NMPA of China
Published: 2024-02-07 (Crawled : 09:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 6.49% | O: 0.76% H: 4.31% C: 2.11%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -2.19% | O: 1.33% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -11.42% | O: -0.65% H: 0.57% C: -3.21%
first management drug application china

---

China Wire and Cable Market Poised for Growth amidst Infrastructure Boom and Technological Innovations, Analysis and Forecast 2023-2032
Published: 2024-01-24 (Crawled : 19:00) - prnewswire.com
PRYMF | $54.0 -27.2% 450 |

Producer Manufacturing

| 26.02% | O: 5.23% H: 0.0% C: 0.0%
PRYMY | $26.515 -3.99% 9K |

Manufacturing

| 16.48% | O: -1.24% H: 0.97% C: 0.92%
BDC | $81.92 0.22% 0.0% 240K |

Producer Manufacturing

| 11.66% | O: 1.1% H: 0.08% C: -0.12%
china growth market

---

China Anti Jamming Market Analysis Report 2023-2028: Growing Military Modernization Drives Demand, Government Initiatives Spur Innovation and Investments
Published: 2024-01-15 (Crawled : 00:00) - prnewswire.com
RTX | $101.56 0.84% 0.11% 6.3M |

Electronic Technology

| 16.59% | O: -0.25% H: 0.2% C: -0.71%
LHX | $205.45 1.67% 0.0% 900K |

Electronic Technology

| -3.08% | O: -0.02% H: 0.11% C: -1.28%
investments report innovation growing military china market

---

Innovent and Xuanzhu Enter into Clinical Trial Collaboration Investigating Combination Therapy of Sintilimab (PD-1 inhibitor) and A Novel ADC Candidate for Advanced Solid Tumors in China
Published: 2023-12-28 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -6.87% | O: 0.28% H: 0.0% C: -1.32%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 29.11% | O: 0.08% H: 0.81% C: -0.19%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -7.68% | O: 0.52% H: 0.72% C: -0.34%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -15.73% | O: 0.35% H: 1.07% C: -0.27%
candidate tumors collaboration trial advanced china therapy

---

Innovent and AnHeart Therapeutics Announce the National Medical Products Administration of China Has Granted Taletrectinib (ROS1 Inhibitor) Priority Review Designation
Published: 2023-12-19 (Crawled : 00:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.07% | O: 0.45% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -12.87% | O: 0.58% H: 2.12% C: 1.53%
granted review designation medical therapeutics china

---

RemeGen Announces Continued Inclusion of Telitacicept and Disitamab Vedotin in China National Reimbursement Drug List, Ensuring Continuous Accessibility of Innovative Drugs for More Patients
Published: 2023-12-18 (Crawled : 13:30) - biospace.com/
SGEN | $228.74 0.1% 20M |

Health Technology

| Email alert Add to watchlist
drug china

---

Innovent Announces Inclusion in the China National Reimbursement Drug List of TYVYT® 's Seventh Indication and BYVASDA®'s Eighth Indication
Published: 2023-12-13 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.13% | O: -0.06% H: 2.36% C: 2.36%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 29.14% | O: 0.32% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.01% | O: -0.27% H: 2.28% C: 2.16%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -14.61% | O: 0.95% H: 3.83% C: 2.79%
tyvyt drug china

---

Fosun International Rated as "2023 Forbes China ESG Innovative Enterprise"
Published: 2023-12-13 (Crawled : 02:00) - prnewswire.com
BAIDF | $11.73 10.95% 17K |

n/a

| -16.32% | O: -1.96% H: 0.8% C: -2.64%
JDCMF | $12.32 -12.99% 390 |

Retail Trade

| -3.75% | O: -2.46% H: 0.0% C: 0.0%
JD | $25.51 0.2% 0.2% 15M |

Retail Trade

| -0.83% | O: -0.71% H: 1.2% C: 1.16%
BIDU | $95.025 -0.58% -0.58% 1.8M |

Technology Services

| -15.4% | O: -0.43% H: 0.0% C: -0.27%
international esg china

---

China's First NDA for a KRAS G12C Inhibitor: Innovent Announces the National Medical Products Administration of China Has Accepted and Granted Priority Review Designation to the New Drug Application for IBI351
Published: 2023-11-24 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -0.32% | O: 0.69% H: 1.66% C: 1.66%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -1.98% | O: 1.46% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -1.09% | O: 0.34% H: 0.37% C: 0.3%
ibi351 drug granted review designation medical application china

---

Innovent and AnHeart Therapeutics Announce the National Medical Products Administration of China Has Accepted the New Drug Application for Taletrectinib (ROS1 Inhibitor)
Published: 2023-11-22 (Crawled : 13:30) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -0.36% | O: -0.74% H: 0.71% C: 0.71%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -2.32% | O: -0.34% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -0.77% | O: 0.56% H: 1.06% C: -0.24%
drug medical application therapeutics china

---

NewLink Signs MOU with China Innovation Centre at Dubai Chambers to Further Advance Green Energy and Sustainability
Published: 2023-11-03 (Crawled : 11:00) - prnewswire.com
NAAS | $0.9903 -3.85% -4.01% 780K |

| -55.16% | O: 4.93% H: 0.0% C: -3.85%
energy innovation china

---

Innovent and RemeGen Enter into Clinical Trial Collaboration Investigating Combination Therapy of TYVYT® (sintilimab injection) and Novel ADC Candidates for Advanced Solid Tumors in China
Published: 2023-06-26 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -11.97% | O: 0.8% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 63.62% | O: 1.4% H: 0.0% C: -2.69%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -15.24% | O: -0.4% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -15.42% | O: 0.06% H: 0.91% C: 0.72%
tyvyt tumors collaboration trial china therapy

---

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology
Published: 2023-06-21 (Crawled : 14:20) - biospace.com/
BMRA | $0.7459 -1.86% -1.89% 35K |

Health Technology

| -53.37% | O: 6.13% H: 0.08% C: -9.25%
patent technology potential china

---

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients
Published: 2023-06-21 (Crawled : 12:00) - globenewswire.com
BMRA | $0.7459 -1.86% -1.89% 35K |

Health Technology

| -53.37% | O: 6.13% H: 0.08% C: -9.25%
patent foods technology potential china

---

Innovent Enters into Clinical Trial Collaboration with Merck KGaA, Darmstadt, Germany Investigating Combination Therapy of IBI351 (KRASG12C Inhibitor) and Cetuximab (ERBITUX®)for KRASG12C-mutated NSCLC in China
Published: 2023-06-02 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -8.59% | O: -0.56% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 72.0% | O: 0.79% H: 1.08% C: 0.54%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -9.41% | O: 1.05% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -14.13% | O: -0.02% H: 1.79% C: 1.69%
ibi351 erbitux merck germany collaboration trial china therapy

---

Vishay Intertechnology 4-Quadrant Silicon PIN Photodiode Receives 2022 China IoT Innovation Award From Elecfans
Published: 2023-05-03 (Crawled : 14:00) - globenewswire.com
VSH | $20.9 -0.85% 0.0% 1M |

Electronic Technology

| -0.28% | O: 0.38% H: 1.93% C: 0.05%
award innovation iot china

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---